Teradyne Unveils New Module for Magnum VU, Enhances Portfolio
Teradyne (TER) rolls out the new Universal Protocol Board module for Magnum VU memory test system which expands its memory test capabilities.
Why Is Teradyne (TER) Down 9.4% Since Last Earnings Report?
Teradyne (TER) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teradyne Extends Memory Test Capabilities with New Magnum VU Test System
NORTH READING, Mass., May 22, 2019 -- Teradyne, Inc. (NASDAQ:TER), a leading supplier of automated test solutions, has announced the new Universal Protocol Board (UPBx), a.
Teradyne Tops VLSIresearch Customer Satisfaction Survey for Seventh Consecutive Year
Teradyne, Inc. (NASDAQ:TER), a leading supplier of automated test solutions, was named "THE BEST" of all test equipment companies for the seventh year in a row by customers in the VLSIresearch annual survey....
MARKETS: Break out the chip stocks—AMAT leading, NVDA sinking ahead of earnings
Semiconductors are lagging the Nasdaq Composite today, but still solidly in the green. Yahoo Finance's Jared Blikre joins Myles Udland to break down the action in the chipmaker space, as President...
Chuck Royce's Firm Trims UniFirst Position, Exits Teradyne
Royce & Associates, the investment firm founded by renowned guru Chuck Royce (Trades, Portfolio), sold shares of the following stocks during the first quarter. Warning! GuruFocus has detected 2 Warning...
Teradyne Declares Quarterly Cash Dividend
NORTH READING, Mass., May 07, 2019 -- Teradyne, Inc. (NASDAQ: TER) today announced a quarterly cash dividend of $0.09 per share, payable on June 21, 2019 to shareholders of.
Should You Worry About Teradyne, Inc.'s (NASDAQ:TER) CEO Pay Cheque?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Mark Jagiela has been the CEO of Teradyne, Inc. (NASDAQ:TER) since 2014. This...
Top Piotroski-Graham Value Stocks For May 2019
These selections continue as an ongoing test and active portfolios for members looking for value stocks using one of the best fundamental value models in the financial literature. Piotroski Value Portfolio...
Semiconductor ETF Tops in April: 5 Stocks Leading the Rally
Inside the five best-performing stocks of the top ETF in April.
TerrAscend Corp. (the “Company”) is a biopharmaceutical and wellness company that is committed to quality products, brands and services for the global cannabinoid market. The Company provides support to patients and consumers through its wholly-owned subsidiaries, TerrAscend Canada Inc., a licensed cannabis producer under the Cannabis Act that provides medical cannabis to patients through its online medical marketplace Solace Health, and Solace Health Network Inc., a clinical support program and education platform led by healthcare professionals. The Company participates in the adult-use market in Canada through direct and indirect supply agreements in several provinces. The Company holds a partnership with leading researchers in Ascendant Labs, a cannabis biotechnology and licensing company committed to the continuous improvement of the cannabis plant, and is pursuing sophisticated pharmaceutical formulations with Solace Rx, a proposed Drug Preparation Premises facility that will deliver formulations to address unmet medical needs where no commercial product is otherwise available.
TerrAscend Canada Inc., a licensed cannabis producer under the Cannabis Act, provides medical cannabis to patients through its online medical marketplace Solace Health.
TerrAscend Canada Inc. also participates in the adult-use market in Canada through direct and indirect supply agreements in several provinces.